Companies /Industrials

Ingersoll-Rand Inc

NYSE: IR Specialty Industrial Machinery
$77.05
▼ $1.53 (−1.95%) today
Markets closed · 6:46pm ET

Q3 2025 Earnings

Reported Oct 30, 2025, 4:42pm ET · SEC source
$0.86
Miss −0.30%
EPS · est. $0.86
$2.0B
Beat +0.36%
Revenue · est. $1.9B
+4.2%
Beating market
IR vs S&P since report
3 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0+3%+6%Oct 30Oct 31report 4:42pm ETearnings−0.1%+0.4%
−3%0+3%+6%Oct 30Oct 31earnings−0.1%+0.4%
IR +0.4%S&P 500 −0.1%
−3%0+3%+6%Oct 30Oct 31report 4:42pm ETearnings−0.1%+0.4%
−3%0+3%+6%Oct 30Oct 31earnings−0.1%+0.4%
IR +0.4%NASDAQ −0.1%
−3%0+3%+6%Oct 29Nov 7report 4:42pm ETearnings−1.8%+2.0%
−3%0+3%+6%Oct 29Nov 7earnings−1.8%+2.0%
IR +2.0%S&P 500 −1.8%
−4%0+4%Oct 29Nov 7report 4:42pm ETearnings−3.4%+2.0%
−4%0+4%Oct 29Nov 7earnings−3.4%+2.0%
IR +2.0%NASDAQ −3.4%
−3.05%
Day of report
−0.43%
Next session
+1.53%
One week
+4.48%
30 days

S&P 500 over the same 30 days: +0.27%.

Did IR Beat Earnings? Q3 2025 Results

Ingersoll Rand posted a mixed third quarter, nudging past revenue expectations while falling just short on the bottom line, as acquisition-driven growth papered over underlying organic softness. The industrial manufacturer reported revenue of $1.96 billion, up 5.0% year-over-year and marginally ahead of the $1.95 billion consensus, but adjusted diluted EPS of $0.86 missed the $0.86 estimate by 0.30%. The story behind the numbers was one of competing forces: M&A contributions of 4.7% and a 1.6% currency tailwind more than offset a 1.3% organic revenue decline, while tariff-related headwinds and continued commercial investments compressed adjusted EBITDA margin by 70 basis points to 27.9%. A bright spot emerged in orders, which grew 8% to $1.94 billion, suggesting demand conditions are gradually improving. Looking ahead, management set full-year 2025 adjusted EPS guidance of $3.25 to $3.31, with total revenue growth of 4% to 6%, even as the organic revenue outlook for both segments sits at negative 2% to flat, reflecting continued near-term caution. The company recently added to its acquisition pipeline with the purchase of U.K.-based ejector solutions provider Transvac Systems, broadening its Industrial Technologies and Services portfolio.

Key Takeaways
  • IRX (Ingersoll Rand Execution Excellence) operating system driving strong performance
  • Positive organic orders growth across both segments for Q3
  • IT&S delivered third consecutive quarter of organic orders growth
  • P&ST organic orders growth in both Precision Technologies and Life Sciences businesses
  • Acquisitions contributed 4.7% to total revenue growth
  • FX contributed 1.6% to revenue growth

“We delivered positive organic orders growth in the third quarter across both segments. Our performance demonstrates the resilience of our business, which combined with our strong balance sheet, enables durable long-term growth. We remain well positioned for future growth with our proven agile business model, operational excellence, and ownership mindset.”

Ingersoll Rand CEO, on the earnings call

Forward Guidance & Outlook

Ingersoll Rand adjusted its full-year 2025 guidance: total revenue growth of 4-6% YoY, organic revenue of (2%)-0% for both segments, FX impact of ~1%, M&A contribution of ~$415M, corporate costs of ~($140M), Adjusted EBITDA of $2,060M-$2,090M (+2% to +4% YoY), and Adjusted EPS of $3.25-$3.31 ((1%) to +1% YoY). Guidance is based on September 2025 FX rates and reflects all completed M&A transactions as of October 30, 2025.

IR YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$600.0M$1.2B$1.8B$1.9B$2.0BRevenue$815.0M$855.2MGross Profit$356.3M$375.5MOperating Income$221.6M$245.8MNet Income
$0$600.0M$1.2B$1.8BRevenueGross ProfitOperating IncomeNet Income

IR Revenue by Segment

Industrial Technologies and Services$1.5B+5.0%
Precision and Science Technologies$414.5M+5.0%

Figures from SEC filings and company reports. Not investment advice.